Valuation CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. Other stock markets 09:08:11 17/07/2026 BST			5-day change	1st Jan Change
8.100 ^HKD	-5.81%		-0.12%	-3.91%

07-17	CSPC Pharmaceutical Group Limited Announces New Drug Application for Trastuzumab Envedotin Injection Accepted by Nmpa	CI
07-17	CSPC Pharma's Application for Breast Cancer Drug Candidate Accepted in China	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	92,608	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	-3.91%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	81,745	79,168	76,106
Change	-	-3.79%	-16.18%	-35.07%	84.76%	-5.73%	-3.15%	-3.87%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	11.2x	13.1x	12x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.16x	1.98x	1.79x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0.1x	-0.9x	1.32x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.6x	2.63x	2.46x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.29x	2.25x	2.02x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	6.49x	7.97x	7.23x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	8.88x	10.4x	9.39x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	9.94x	11.3x	7.95x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	10.1%	8.87%	12.6%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.3633	0.3682	0.3827
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	4.49%	4.55%	4.72%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.7213	0.6181	0.6742
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	50.4%	59.6%	56.8%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	35,677	35,195	37,634
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	12,600	9,933	10,533
EBIT ¹	8,366	7,952	7,400	6,113	5,564	9,206	7,644	8,108
Net income ¹	6,901	6,949	6,382	4,632	4,409	7,937	6,917	7,537
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-10,863	-13,439	-16,502
Reference price ²	8.470	8.200	7.260	4.780	8.430	8.100	8.100	8.100
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	-	-
Announcement Date	22/03/22	22/03/23	20/03/24	28/03/25	25/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	11.23x	2.29x	6.49x	4.49%	11.81B
ELI LILLY AND COMPANY	35.04x	12.53x	26.21x	0.57%	1,051B
JOHNSON & JOHNSON	27.19x	6.2x	16.98x	2.12%	609B
ABBVIE INC.	33.15x	7.52x	15.43x	2.7%	450B
ROCHE HOLDING AG	17.85x	4.43x	10.91x	3%	330B
NOVARTIS AG	21.66x	5.55x	13.44x	2.84%	284B
ASTRAZENECA PLC	21.16x	4.46x	12.34x	1.97%	263B
NOVO NORDISK A/S	14.44x	5.41x	11.14x	3.44%	223B
AMGEN INC.	24.02x	6.35x	11.22x	2.75%	198B
GILEAD SCIENCES, INC.	-48.37x	5.78x	31.95x	2.42%	167B
Average	15.74x	6.05x	15.61x	2.63%	358.69B
Weighted average by Cap.	23.97x	7.81x	18.29x	2.01%